Conjunctive Effects of the 5HT2 Receptor Antagonist, Sarpogrelate, on Thrombolysis with Modified Tissue Plasminogen Activator in Different Laser-Induced Thrombosis Models

Publisher： Karger

E-ISSN： 1424-8840|30|6|321-332

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.6, 2001-05, pp. : 321-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag®), a selective 5-HT2 receptor antagonist: an in vitro study

By Nakamura Ken   Kawahito Koji  

Journal of Artificial Organs, Vol. 13, Iss. 3, 2010-09 ,pp. : 178-181

Springer Publishing Company

Access to resources Recommend Favorite

QoL evaluation of olanzapine for chemotherapy‐induced nausea and vomiting comparing with 5‐HT3 receptor antagonist

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 3, 2015-05 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic Hemostasis With Recombinant-Activated Factor VII Followed by Local Thrombolysis With Recombinant Tissue Plasminogen Activator in Intraventricular Hemorrhage

By Ionita Catalina C.   Ferrara Joseph   McDonagh David L.   Grossi Peter   Graffagnino Carmelo  

Neurocritical Care, Vol. 3, Iss. 3, 2005-12 ,pp. : 246-248

Humana Press, Inc

Access to resources Recommend Favorite

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Intrauterine Upper Extremity Thrombosis Successfully Treated with Recombinant Tissue Plasminogen Activator, Enoxaparin and Collagenase

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-03 ,pp. : 189-192

Karger

Access to resources Recommend Favorite